Category Archives: Research
Booth at BMB2015(2015 12.1-4)
We had a lot of visitors at our exhibition booth in BMB2015 in Kobe. (BMB2015)
Thank you very much for sparing your time to visit us.
Postdoctoral fellow,Philip Prathipati will present his work at 9th Vaccine & ISV Congress in Korea(2015.10).
Postdoctoral fellow,Philip Prathipati will present his work “A systems Biology Framework for the identification of the molecular basis of immune adjuvanticity”
9th Vaccine & ISV congress
Lotte hotel, Seoul, South Korea
October 18, 14:10-14:25
Postdoctoral Fellow, Lokesh P. Tripathi will present his work at 9th Vaccine&ISV Congress in Korea(2015.10).
Postdoctoral Fellow,Lokesh P.Tripathi will present his work “A systems level analysis of adjuvant transcriptomes for biomarker and target discovery”
9th Vaccine & ISV Congress,
Lotte Hotel, Seoul, South Korea
October 18, 15:25-15:40
Postdoctoral Fellow,Lokesh P.Tripathi presented his work "Effective characterisation of adjuvant transcriptomes for biomarker and target discovery"at The 12th [BC]2 – the Basel Computational Biology Conference(2015.6.7)
Postdoctoral Fellow,Lokesh P.Tripathi presented his work “Effective characterisation of adjuvant transcriptomes for biomarker and target discovery”
[BC]2 – the Basel Computational Biology Conference:Congress Center Basel, Messeplatz, 25, Basel, 4005, Switzerland
Date of presentation: June 7th, 2015
The TOGO TV movie ”Tutorial movies for TargetMine ~ List Search, QueryBuilder ~” has been released. (2015-3-13)
Go to the TOGO TV page.
"Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing." has been published in PLoS One. (2015-2-27)
Pathway-Based Analysis of Genome-Wide siRNA Screens Reveals the Regulatory Landscape of App Processing.
Camargo LM, Zhang XD, Loerch P, Caceres RM, Marine SD, Uva P, Ferrer M, Rinaldis E, Stone DJ, Majercak J, Ray WJ, Yi-An C, Shearman MS, Mizuguchi K.
PubMed:25723573
Abstract
The progressive aggregation of Amyloid-β (Aβ) in the brain is a major trait of Alzheimer’s Disease (AD). Aβ is produced as a result of proteolytic processing of the β-amyloid precursor protein (APP). Processing of APP is mediated by multiple enzymes, resulting in the production of distinct peptide products: the non-amyloidogenic peptide sAPPα and the amyloidogenic peptides sAPPβ, Aβ40, and Aβ42. Using a pathway-based approach, we analyzed a large-scale siRNA screen that measured the production of different APP proteolytic products. Our analysis identified many of the biological processes/pathways that are known to regulate APP processing and have been implicated in AD pathogenesis, as well as revealing novel regulatory mechanisms. Furthermore, we also demonstrate that some of these processes differentially regulate APP processing, with some mechanisms favouring production of certain peptide species over others. For example, synaptic transmission having a bias towards regulating Aβ40 production over Aβ42 as well as processes involved in insulin and pancreatic biology having a bias for sAPPβ production over sAPPα. In addition, some of the pathways identified as regulators of APP processing contain genes (CLU, BIN1, CR1, PICALM, TREM2, SORL1, MEF2C, DSG2, EPH1A) recently implicated with AD through genome wide association studies (GWAS) and associated meta-analysis. In addition, we provide supporting evidence and a deeper mechanistic understanding of the role of diabetes in AD. The identification of these processes/pathways, their differential impact on APP processing, and their relationships to each other, provide a comprehensive systems biology view of the “regulatory landscape” of APP.
The TOGO TV movie ”Tutorial movies for TargetMine ~keyword, Template Search~” has been released. (2015-2-6)
Go to the TOGO TV page.
Research Scientist. Shandar Ahmad presented his work “Nature of affinity, specificity and TF-chromatin preferences in protein-DNA interactions” at the The MRC Laboratory of Molecular Biology (LMB). (2015-1-26)
Research Scientist. Shandar Ahmad presented his work “Nature of affinity, specificity and TF-chromatin preferences in protein-DNA interactions” at the The MRC Laboratory of Molecular Biology (LMB), Cambridge University, UK.
"PoSSuM v.2.0: data update and a new function for investigating ligand analogs and target proteins of small-molecule drugs." has been published in Nucleic Acids Research. (2014-11-17)
PoSSuM v.2.0: data update and a new function for investigating ligand analogs and target proteins of small-molecule drugs.
Ito JI, Ikeda K, Yamada K, Mizuguchi K, Tomii K.
PubMed:25404129
Abstract
PoSSuM (http://possum.cbrc.jp/PoSSuM/) is a database for detecting similar small-molecule binding sites on proteins. Since its initial release in 2011, PoSSuM has grown to provide information related to 49 million pairs of similar binding sites discovered among 5.5 million known and putative binding sites. This enlargement of the database is expected to enhance opportunities for biological and pharmaceutical applications, such as predictions of new functions and drug discovery. In this release, we have provided a new service named PoSSuM drug search (PoSSuMds) at http://possum.cbrc.jp/PoSSuM/drug_search/, in which we selected 194 approved drug compounds retrieved from ChEMBL, and detected their known binding pockets and pockets that are similar to them. Users can access and download all of the search results via a new web interface, which is useful for finding ligand analogs as well as potential target proteins. Furthermore, PoSSuMds enables users to explore the binding pocket universe within PoSSuM. Additionally, we have improved the web interface with new functions, including sortable tables and a viewer for visualizing and downloading superimposed pockets.